Skip to main content
Top
Published in: European Radiology 11/2019

01-11-2019 | Computed Tomography | Chest

Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics

Authors: Xiance Jin, Xiaomin Zheng, Didi Chen, Juebin Jin, Guojie Zhu, Xia Deng, Ce Han, Changfei Gong, Yongqiang Zhou, Cong Liu, Congying Xie

Published in: European Radiology | Issue 11/2019

Login to get access

Abstract

Purpose

To investigate the treatment response prediction feasibility and accuracy of an integrated model combining computed tomography (CT) radiomic features and dosimetric parameters for patients with esophageal cancer (EC) who underwent concurrent chemoradiation (CRT) using machine learning.

Methods

The radiomic features and dosimetric parameters of 94 EC patients were extracted and modeled using Support Vector Classification (SVM) and Extreme Gradient Boosting algorithm (XGBoost). The 94-sample dataset was randomly divided into a 70-sample training subset and a 24-sample independent test set while keeping the class proportions intact via stratification. A receiver operating characteristic (ROC) curve was used to assess the performance of models using radiomic features alone and using combined radiomic features and dosimetric parameters.

Results

A total of 42 radiomic features and 18 dosimetric parameters plus the patients’ characteristic parameters were extracted for these 94 cases (58 responders and 36 non-responders). XGBoost plus principal component analysis (PCA) achieved an accuracy and area under the curve of 0.708 and 0.541, respectively, for models with radiomic features combined with dosimetric parameters, and 0.689 and 0.479, respectively, for radiomic features alone. Image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the model. The dosimetric parameters of gross tumor volume (GTV) homogeneity index (HI), Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.

Conclusions

The model with radiomic features combined with dosimetric parameters is promising and outperforms that with radiomic features alone in predicting the treatment response of patients with EC who underwent CRT.

Key Points

• The model with radiomic features combined with dosimetric parameters is promising in predicting the treatment response of patients with EC who underwent CRT.
• The model with radiomic features combined with dosimetric parameters (prediction accuracy of 0.708 and AUC of 0.689) outperforms that with radiomic features alone (best prediction accuracy of 0.625 and AUC of 0.412).
• The image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the treatment response prediction model. The dosimetric parameters of GTV HI, Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.
Literature
1.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef
2.
go back to reference Wheeler JB, Reed CE (2012) Epidemiology of esophageal cancer. Surg Clin North Am 92:1077–1087CrossRef Wheeler JB, Reed CE (2012) Epidemiology of esophageal cancer. Surg Clin North Am 92:1077–1087CrossRef
3.
go back to reference Kumagai K, Rouvelas I, Tsai JA et al (2014) Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 101:321–338CrossRef Kumagai K, Rouvelas I, Tsai JA et al (2014) Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 101:321–338CrossRef
4.
go back to reference Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J (2016) Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 11:18CrossRef Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J (2016) Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 11:18CrossRef
5.
go back to reference Minsky BD, Neuberg D, Kelsen DP et al (1999) Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517–523CrossRef Minsky BD, Neuberg D, Kelsen DP et al (1999) Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517–523CrossRef
6.
go back to reference Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef
7.
go back to reference Ajani JA (2008) Gastroesophageal cancers: progress and problems. J Natl Compr Canc Netw 6:813–814CrossRef Ajani JA (2008) Gastroesophageal cancers: progress and problems. J Natl Compr Canc Netw 6:813–814CrossRef
8.
go back to reference Luo Y, Mao Q, Wang X, Yu J, Li M (2017) Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res 10:13–21CrossRef Luo Y, Mao Q, Wang X, Yu J, Li M (2017) Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res 10:13–21CrossRef
9.
go back to reference Li JC, Liu D, Chen MQ et al (2012) Different radiation treatment in esophageal carcinoma: a clinical comparative study. J BUON 17:512–516PubMed Li JC, Liu D, Chen MQ et al (2012) Different radiation treatment in esophageal carcinoma: a clinical comparative study. J BUON 17:512–516PubMed
10.
go back to reference Chen YJ, Liu A, Han C et al (2007) Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 32:166–171CrossRef Chen YJ, Liu A, Han C et al (2007) Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 32:166–171CrossRef
11.
go back to reference Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184–2192CrossRef Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184–2192CrossRef
12.
go back to reference Chao YK, Chan SC, Liu YH et al (2009) Pretreatment T3–4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg 249:392–396CrossRef Chao YK, Chan SC, Liu YH et al (2009) Pretreatment T3–4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg 249:392–396CrossRef
13.
go back to reference Hammoud ZT, Kesler KA, Ferguson MK et al (2006) Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus 19:69–72CrossRef Hammoud ZT, Kesler KA, Ferguson MK et al (2006) Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus 19:69–72CrossRef
14.
go back to reference Muijs CT, Beukema JC, Pruim J et al (2010) A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165–171CrossRef Muijs CT, Beukema JC, Pruim J et al (2010) A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165–171CrossRef
15.
go back to reference Foley KG, Hills RK, Berthon B et al (2018) Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol 28(1):428–436CrossRef Foley KG, Hills RK, Berthon B et al (2018) Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol 28(1):428–436CrossRef
16.
go back to reference Miles KA, Lee TY, Goh V et al (2012) Experimental Cancer Medicine Centre Imaging Network Group. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol 22:1430–1441CrossRef Miles KA, Lee TY, Goh V et al (2012) Experimental Cancer Medicine Centre Imaging Network Group. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol 22:1430–1441CrossRef
17.
go back to reference Djuric-Stefanovic A, Micev M, Stojanovic-Rundic S, Pesko P, Dj S (2015) Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade. Eur J Radiol 84:2477–2484CrossRef Djuric-Stefanovic A, Micev M, Stojanovic-Rundic S, Pesko P, Dj S (2015) Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade. Eur J Radiol 84:2477–2484CrossRef
18.
go back to reference Desborders P, Ruan S, Modzelewski R et al (2017) Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier. PLoS One 12:e0173208CrossRef Desborders P, Ruan S, Modzelewski R et al (2017) Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier. PLoS One 12:e0173208CrossRef
19.
go back to reference Tixier F, Rest CC, Hatt M et al (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRef Tixier F, Rest CC, Hatt M et al (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRef
20.
go back to reference Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in esophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in esophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef
21.
go back to reference Hou Z, Ren W, Li S et al (2017) Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget 8:104444–104454PubMedPubMedCentral Hou Z, Ren W, Li S et al (2017) Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget 8:104444–104454PubMedPubMedCentral
22.
go back to reference Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C (2013) CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer. J Appl Clin Med Phys 14:153–161CrossRef Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C (2013) CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer. J Appl Clin Med Phys 14:153–161CrossRef
23.
go back to reference Wu Z, Xie C, Hu M et al (2014) Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option? J Appl Clin Med Phys 15:93–101CrossRef Wu Z, Xie C, Hu M et al (2014) Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option? J Appl Clin Med Phys 15:93–101CrossRef
24.
go back to reference Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE (2015) IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys 42:1341–1353CrossRef Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE (2015) IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys 42:1341–1353CrossRef
25.
go back to reference Blaas J, Botha CP, Post FH (2008) Extensions of parallel coordinates for interactive exploration of large multi-timepoint data sets. IEEE Trans Vis Comput Graph 14:1436–1443CrossRef Blaas J, Botha CP, Post FH (2008) Extensions of parallel coordinates for interactive exploration of large multi-timepoint data sets. IEEE Trans Vis Comput Graph 14:1436–1443CrossRef
26.
go back to reference Burges CJC (1998) A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov 2:121–167CrossRef Burges CJC (1998) A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov 2:121–167CrossRef
27.
go back to reference Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. AcmSigkdd international conference on Knowledge Discovery & Data Mining, pp 785–94 Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. AcmSigkdd international conference on Knowledge Discovery & Data Mining, pp 785–94
28.
go back to reference Minka TP (2001) Automatic choice of dimensionality for PCA. In: Advances in neural information processing systems, pp 598–604 Minka TP (2001) Automatic choice of dimensionality for PCA. In: Advances in neural information processing systems, pp 598–604
29.
go back to reference Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef
30.
go back to reference Yip C, Davnall F, Kozarski R, Landau DB et al (2015) Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus 28:172–179CrossRef Yip C, Davnall F, Kozarski R, Landau DB et al (2015) Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus 28:172–179CrossRef
31.
32.
go back to reference O'Sullivan KE, Hurley ET, Hurley JP (2015) Understanding complete pathologic response in oesophageal cancer: implications for management and survival. Gastroenterol Res Pract 2015(2015):518281PubMedPubMedCentral O'Sullivan KE, Hurley ET, Hurley JP (2015) Understanding complete pathologic response in oesophageal cancer: implications for management and survival. Gastroenterol Res Pract 2015(2015):518281PubMedPubMedCentral
Metadata
Title
Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics
Authors
Xiance Jin
Xiaomin Zheng
Didi Chen
Juebin Jin
Guojie Zhu
Xia Deng
Ce Han
Changfei Gong
Yongqiang Zhou
Cong Liu
Congying Xie
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06193-w

Other articles of this Issue 11/2019

European Radiology 11/2019 Go to the issue